Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP832663.RAWiTrwgeavypUiwKUkpjaWStWTC72SC8y9e5rH_FkyFM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP832663.RAWiTrwgeavypUiwKUkpjaWStWTC72SC8y9e5rH_FkyFM130_assertion type Assertion NP832663.RAWiTrwgeavypUiwKUkpjaWStWTC72SC8y9e5rH_FkyFM130_head.
- NP832663.RAWiTrwgeavypUiwKUkpjaWStWTC72SC8y9e5rH_FkyFM130_assertion description "[Our observations validate PAX2 as a potential therapeutic gene target in renal cancer and suggest that adjunctive PAX2 knockdown may enhance the efficacy of other chemotherapeutic agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP832663.RAWiTrwgeavypUiwKUkpjaWStWTC72SC8y9e5rH_FkyFM130_provenance.
- NP832663.RAWiTrwgeavypUiwKUkpjaWStWTC72SC8y9e5rH_FkyFM130_assertion evidence source_evidence_literature NP832663.RAWiTrwgeavypUiwKUkpjaWStWTC72SC8y9e5rH_FkyFM130_provenance.
- NP832663.RAWiTrwgeavypUiwKUkpjaWStWTC72SC8y9e5rH_FkyFM130_assertion SIO_000772 18439754 NP832663.RAWiTrwgeavypUiwKUkpjaWStWTC72SC8y9e5rH_FkyFM130_provenance.
- NP832663.RAWiTrwgeavypUiwKUkpjaWStWTC72SC8y9e5rH_FkyFM130_assertion wasDerivedFrom befree-20140225 NP832663.RAWiTrwgeavypUiwKUkpjaWStWTC72SC8y9e5rH_FkyFM130_provenance.
- NP832663.RAWiTrwgeavypUiwKUkpjaWStWTC72SC8y9e5rH_FkyFM130_assertion wasGeneratedBy ECO_0000203 NP832663.RAWiTrwgeavypUiwKUkpjaWStWTC72SC8y9e5rH_FkyFM130_provenance.